During the past trading week (February 3 to 7), a Canadian cannabis producer lost its longtime leader and announced cuts to improve profitability.

A battered cannabis firm took another major hit after a superior court allowed for a class-action lawsuit to be carried through, and a multimillion-dollar deal was finally closed after months of uncertainty.

Here’s a closer look at some of the biggest cannabis news over the week.

Aurora loses CEO, joins Tilray in cutting 10 percent of staff

Another well-known name in the Canadian cannabis industry has fallen, with Terry Booth, former CEO of Aurora Cannabis (NYSE:ACB,TSX:ACB), declaring his retirement after seven years at the helm.

The Thursday (February 6) announcement states that Aurora’s executive chairman, Michael Singer, will succeed Booth as interim CEO effective immediately, though Booth will still serve on the board.

Aurora’s board of directors is also welcoming two new players: Lance Friedmann and Michael Detlefsen.

In a call with analysts after market close on Thursday, Singer said the change has Booth’s full support and that the former CEO “recognizes that the next leg of our journey will be best led by a CEO with a different skill set.”

Aurora’s leadership change comes just a day after BNN Bloomberg reported the Alberta-based cannabis producer is planning to cut its workforce of about 3,400 employees by 10 percent.

With the announcement of Booth’s departure, the company also confirmed plans to bring its capital expenditures below C$100 million for the second half of the 2020 fiscal year amid a series of disappointing quarterly results.

Aurora expects impairment charges on certain intangible property, plants and equipment to cost from C$190 million to C$225 million. There will also be a goodwill writedown of up to C$775 million.

The company isn’t expecting much growth when it comes to revenue in the upcoming quarter. Due to industry headwinds, including a dip in international revenues and low bulk sales, the firm estimates little to no quarter-over-quarter change in Q2 2020, with revenue projections of C$62 million to C$66 million.

Singer also blamed a slow rollout of retail stores in key provinces, changes in the purchasing patterns of provincial distributors and shifting consumer preferences on the firm’s less-than-impressive gains.

“We believe our succession plan, expansion of the board and the rationalization of our business will make Aurora much stronger and more focused than ever before,” Singer said.

Along with Aurora, Tilray (NASDAQ:TLRY) also announced plans to downsize its staff to reduce costs.

On Tuesday (February 4), the British Columbia-based company told news outlets that it is cutting 10 percent of its staff to reach its profitability goals.

In a statement to the Financial Post, Brendan Kennedy, CEO of Tilray, said the decision to cut its staff of over 1,400 employees wasn’t taken lightly.

“By reducing headcount and cost, Tilray will be better positioned to achieve profitability,” Kennedy said.

Since the announcement, Aurora’s share price has fallen 17.4 percent from market close on Thursday to market open on Friday (February 7). Tilray fared a bit better, dropping only 1.8 percent from the start of the trading session on Tuesday to market open on Friday.

Aurora and Tilray’s woes are just some in a recent group of losses and departures that have plagued the marijuana industry in the past weeks.

Both Sundial Growers (NASDAQ:SNDL) and MedMen Enterprises (CSE:MMEN,OTCQX:MMNFF) lost their respective leaders last week. Earlier in the year, TerrAscend (CSE:TER,OTCQX:TRSSF) and The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) let go of their CEOs as well.

CannTrust faces class-action lawsuit

Beleaguered cannabis firm CannTrust Holdings (NYSE:CTST,TSX:TRST) is up against its newest challenge after the Ontario Superior Court of Justice confirmed that a team of Ontario-based law firms will be allowed to carry out a proposed securities class action against the firm.

On Monday (February 3), the law firms said the action was in connection to CannTrust’s failure to disclose the non-compliant cultivation of cannabis in some of its facilities. The breach was revealed last summer.

In the fallout, the firm lost some of its key members, including former CEO Peter Aceto and former Chairman Eric Paul, and had its cultivation and production license suspended.

More recently, in December, CannTrust was told it was on the brink of being delisted from the New York Stock Exchange as its share price slipped below the US$1 threshold that the exchange requires to remain an active lister.

CannTrust has lost a stunning 75 percent of its value in New York since the news of its illegal growing operations broke. As of 2:08 p.m. EST on Friday, it sat at US$0.93.

Market updates

Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) was one firm that got a win this past week when it closed its acquisition of Cura Partners, the owner of the Select brand.

The deal’s end has been a long time coming as it was first announced in May of last year. Curaleaf’s deal did spend some time under the eye of antitrust regulators due to the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

With Cura Partners’ assets, Curaleaf now has 53 dispensaries across the US in its portfolio.

The transaction was originally valued at US$948.8 million, but the firm told investors in October that it was amending the terms of the deal due to unfavorable market conditions.

Innovative Industrial Properties (NYSE:IIPR) announced a partnership with Illinois-based Green Thumb Industries (CSE:GTII,OTCQX:GTBIF), starting with a sale leaseback deal for a processing facility in Ohio.

Another real estate investor, the energy– and transportation-focused Power REIT (NYSEAMERICAN:PW), stepped into the cannabis space after purchasing two marijuana greenhouse properties in Southern Colorado for US$3.75 million.

While Power was moving into cannabis, marijuana producer Australis Capital (CSE:AUSA,OTC:AUSAF) branched out into fintech with the acquisition of Paytron, a payment service provider that specializes in secure processing and point-of-sale hardware, among other technologies.

Also in the US, iAnthus Capital Holdings (CSE:IAN,OTCQX:ITHUF) got the green light to begin its operations in New Jersey at its Pleasantville cultivation campus.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less